BioVie Inc. Shareholders' Equity
BioVie Inc. (BIVI) had Shareholders' Equity of $10.27 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $10.27M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $15.61M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $19.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $24.92M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $10.27M 10-K · filed 2026-08-13 | |
| 2026-03-31 | $15.61M S-1/A · filed 2026-08-06 | |
| 2025-12-31 | $19.27M S-1/A · filed 2026-08-06 | |
| 2025-09-30 | $24.92M S-1/A · filed 2026-08-06 | |
| 2025-06-30 | $19.01M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $21.82M S-1/A · filed 2026-08-06 | |
| 2024-12-31 | $23.92M S-1/A · filed 2026-08-06 | |
| 2024-09-30 | $14.07M S-1/A · filed 2026-08-06 | |
| 2024-06-30 | $15.51M 10-K · filed 2026-08-13 | |
| 2024-03-31 | $18.93M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $7.49M 10-Q · filed 2025-05-12 | |
| 2023-09-30 | $7.55M 10-Q · filed 2025-05-12 | |
| 2023-06-30 | $15.34M 10-K · filed 2025-08-15 | |
| 2023-03-31 | $21.72M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $26.07M 10-Q · filed 2024-05-14 | |
| 2022-09-30 | $5.96M 10-Q · filed 2024-05-14 | |
| 2022-06-30 | $3.67M 10-K · filed 2024-09-30 | |
| 2022-03-31 | $9.95M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $16.07M 10-Q · filed 2023-05-12 | |
| 2021-09-30 | $20.23M 10-Q · filed 2023-05-12 | |
| 2021-06-30 | $5.05M 10-K · filed 2023-08-16 | |
| 2021-03-31 | $11.40M 10-Q · filed 2022-05-11 | |
| 2020-12-31 | $13.07M 10-Q · filed 2022-05-11 | |
| 2020-09-30 | $14.60M 10-Q · filed 2022-05-11 | |
| 2020-06-30 | -$21.50M 10-K · filed 2022-09-27 | |
| 2020-03-31 | -$2.34M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$2.04M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | -$8.72M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $2.13M 10-K · filed 2021-08-30 | |
| 2019-05-10 | $2.79M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.54M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $4.02M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $111.20K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $555.44K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $791.07K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $1.08M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.16M 10-K · filed 2018-10-05 | $1.16M 10-K · filed 2017-08-24 |
| 2017-03-31 | $1.47M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $1.33M 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $1.58M 10-Q/A · filed 2017-01-19 | |
| 2016-06-30 | $1.92M 10-Q · filed 2017-11-08 | |
| 2016-03-31 | -$211.46K 10-Q · filed 2016-05-23 | |
| 2015-12-31 | -$154.78K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$106.80K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$54.12K 10-K · filed 2017-08-24 | |
| 2015-03-31 | -$1.20K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $45.91K 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $114.50K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $171.39K 10-Q · filed 2017-05-09 | |
| 2014-03-31 | $357.04K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $390.08K 10-Q · filed 2014-01-29 | |
| 2013-09-30 | $437.20K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $490.70K 10-Q · filed 2016-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |